| Lactose (India) Ltd | 145 Cr. | 115 | 247/84.3 | 33.0 | 46.7 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.63 Cr. | 1.90 | 4.33/1.90 | | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 5,079 Cr. | 464 | 479/192 | 114 | 22.8 | 0.14 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 34.5 Cr. | 46.5 | 94.9/37.2 | | 8.73 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 35.1 Cr. | 24.0 | 29.1/17.0 | 36.6 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 65.3 Cr. | 86.7 | 134/78.9 | 17.2 | 57.6 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 53,597 Cr. | 1,898 | 2,286/1,275 | 40.2 | 314 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 352 Cr. | 15.5 | 22.5/10.8 | 21.4 | 8.21 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.06 Cr. | 14.6 | 19.2/9.25 | 88.2 | 14.7 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 734 Cr. | 1,554 | 1,785/635 | 31.3 | 299 | 0.05 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 108 Cr. | 21.6 | 32.0/15.0 | 33.0 | 11.1 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 828 Cr. | 281 | 449/219 | 7.92 | 123 | 0.89 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 4.83 Cr. | 23.0 | 39.0/22.8 | 37.2 | 20.4 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 11.6 Cr. | 4.67 | 9.28/2.11 | 6.61 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 388 Cr. | 400 | 477/112 | 62.6 | 72.0 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,806 Cr. | 1,104 | 1,584/1,045 | 46.9 | 396 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 55.2 Cr. | 0.27 | 1.24/0.26 | 3.63 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 46.9 Cr. | 19.5 | 26.3/6.40 | 48.4 | 16.0 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 9.82 Cr. | 9.73 | 17.2/9.01 | | 22.6 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 177 Cr. | 495 | 896/443 | 9.57 | 563 | 0.30 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 67.0 Cr. | 67.0 | 71.5/26.1 | 172 | 34.1 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 15,388 Cr. | 1,470 | 2,452/1,345 | 43.1 | 173 | 0.73 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 19.4 Cr. | 42.4 | 88.7/37.6 | 42.2 | 21.6 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 18.1 Cr. | 7.23 | 7.23/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 18.6 Cr. | 124 | 154/63.0 | | 87.6 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 38.1 Cr. | 69.6 | 69.6/9.41 | 423 | 1.02 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 31.0 Cr. | 41.1 | 80.0/0.00 | 43.7 | 39.7 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.33 Cr. | 21.1 | 26.0/15.5 | | 11.2 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 11,694 Cr. | 674 | 1,028/468 | 32.6 | 65.3 | 0.18 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 88.2 Cr. | 20.4 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 11.7 Cr. | 23.2 | 43.7/17.4 | 51.1 | 18.7 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 99,110 Cr. | 2,400 | 3,055/2,115 | 54.8 | 355 | 0.04 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 244 Cr. | 424 | 524/241 | 25.6 | 119 | 1.06 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 47.1 Cr. | 32.8 | 62.6/31.6 | 42.4 | 17.7 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 67,902 Cr. | 1,159 | 1,417/994 | 20.0 | 557 | 0.35 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 123 Cr. | 197 | 303/170 | 178 | 69.0 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 893 Cr. | 89.2 | 123/74.0 | 19.4 | 32.5 | 1.68 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 40.2 Cr. | 30.8 | 50.0/21.0 | | 51.2 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 14,855 Cr. | 1,810 | 1,868/919 | 66.3 | 160 | 0.08 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.23 Cr. | 0.64 | 1.45/0.55 | 84.5 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 247 Cr. | 32.3 | 68.0/30.0 | 13.2 | 18.3 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 8.71 Cr. | 14.9 | 25.5/9.40 | | 2.55 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 130 Cr. | 5.53 | 6.57/2.82 | 303 | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 61,682 Cr. | 29,035 | 37,000/25,260 | 42.5 | 1,992 | 1.64 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 7,787 Cr. | 858 | 972/550 | 29.2 | 220 | 0.58 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 274 Cr. | 96.2 | 96.9/31.3 | 66.0 | 48.8 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 4,778 Cr. | 1,575 | 1,628/535 | | 104 | 0.06 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 22,977 Cr. | 1,414 | 1,870/1,110 | 419 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 920 Cr. | 264 | 330/154 | 21.4 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 4.24 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 593 Cr. | 444 | 568/270 | 12.7 | 420 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 3,354 Cr. | 475 | 950/455 | 26.8 | 348 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,665 Cr. | 1,175 | 1,595/991 | 23.6 | 768 | 0.85 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,22,827 Cr. | 3,628 | 3,790/2,886 | 60.8 | 224 | 0.88 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 1,149 Cr. | 125 | 317/98.0 | | 43.7 | 0.40 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,558 Cr. | 16.6 | 24.0/14.1 | 27.4 | 3.62 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 28,427 Cr. | 743 | 1,360/730 | 80.8 | 66.6 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 4,659 Cr. | 205 | 303/102 | | 5.04 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,09,628 Cr. | 1,706 | 1,910/1,547 | 35.7 | 301 | 0.94 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,813 Cr. | 632 | 886/441 | 115 | 304 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 2,633 Cr. | 282 | 319/175 | 37.5 | 75.9 | 0.14 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 7,153 Cr. | 367 | 502/265 | 55.6 | 121 | 0.14 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 5,472 Cr. | 218 | 232/111 | 181 | 28.1 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 11,016 Cr. | 4,783 | 6,823/4,146 | 29.8 | 340 | 2.45 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 4,032 Cr. | 2,441 | 2,776/1,772 | 36.2 | 335 | 0.82 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 10,089 Cr. | 6,086 | 6,739/4,904 | 33.6 | 323 | 2.05 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 176 Cr. | 49.8 | 87.5/42.0 | | 16.8 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 23,711 Cr. | 5,182 | 5,993/3,701 | 35.1 | 922 | 0.68 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 125 Cr. | 102 | 348/81.0 | 8.84 | 80.4 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,646 Cr. | 432 | 582/281 | | 136 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 3,909 Cr. | 770 | 1,998/604 | 45.9 | 250 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 21,957 Cr. | 17,159 | 18,100/10,060 | 167 | 1,188 | 0.07 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 328 Cr. | 14.8 | 44.9/13.0 | | 42.6 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 14,888 Cr. | 832 | 1,505/660 | 8.77 | 425 | 0.72 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,637 Cr. | 48.2 | 91.7/41.7 | 28.5 | 21.1 | 0.42 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 8,634 Cr. | 190 | 359/162 | 24.7 | 54.4 | 0.42 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 105 Cr. | 67.0 | 130/62.8 | | 93.9 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 338 Cr. | 94.6 | 177/90.2 | 45.0 | 29.0 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 90,578 Cr. | 1,984 | 2,403/1,774 | 24.5 | 377 | 0.60 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,066 Cr. | 533 | 980/499 | 12.4 | 335 | 0.34 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 52,608 Cr. | 975 | 980/474 | 77.0 | 91.1 | 0.12 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 916 Cr. | 883 | 1,235/596 | 21.1 | 256 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 149 Cr. | 69.4 | 129/63.6 | | 67.8 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 800 Cr. | 166 | 327/154 | 22.9 | 107 | 1.81 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 657 Cr. | 378 | 500/265 | 23.5 | 116 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 18,693 Cr. | 1,170 | 1,310/802 | 37.6 | 414 | 0.43 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 26,848 Cr. | 1,712 | 1,955/1,303 | 39.2 | 221 | 0.91 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,512 Cr. | 226 | 328/193 | 35.5 | 36.1 | 1.10 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 33,202 Cr. | 1,310 | 1,758/1,168 | 37.1 | 274 | 0.31 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,771 Cr. | 94.5 | 127/57.5 | 26.3 | 57.5 | 0.85 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 751 Cr. | 102 | 124/67.2 | 34.1 | 194 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 2,547 Cr. | 275 | 355/190 | | 111 | 0.07 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 3,002 Cr. | 244 | 465/236 | 47.4 | 102 | 0.57 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,388 Cr. | 1,630 | 2,786/1,243 | 36.9 | 369 | 0.43 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,297 Cr. | 328 | 504/285 | 53.9 | 60.0 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 13,928 Cr. | 574 | 628/412 | 29.2 | 153 | 0.26 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 53,597 Cr. | 1,898 | 2,286/1,275 | 40.2 | 314 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 45,350 Cr. | 2,683 | 3,516/1,921 | 47.9 | 115 | 1.57 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 32,480 Cr. | 1,972 | 2,131/1,200 | 28.1 | 610 | 0.91 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 7,491 Cr. | 460 | 559/359 | 27.8 | 140 | 1.09 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 21,795 Cr. | 1,597 | 1,910/1,097 | 56.3 | 210 | 0.46 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 99,807 Cr. | 1,196 | 1,406/1,020 | 17.3 | 432 | 0.67 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 4,582 Cr. | 292 | 322/177 | 38.6 | 372 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,22,066 Cr. | 1,512 | 1,673/1,310 | 22.4 | 408 | 0.86 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 15,247 Cr. | 2,006 | 2,641/1,551 | 27.0 | 347 | 0.30 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 329 Cr. | 112 | 203/95.6 | 162 | 33.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,643 Cr. | 155 | 191/105 | 15.4 | 99.7 | 0.32 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 65.2 Cr. | 39.8 | 72.1/38.0 | 23.4 | 11.5 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 50,437 Cr. | 377 | 406/291 | 139 | 180 | 0.13 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,834 Cr. | 1,817 | 2,215/1,430 | 40.0 | 195 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 132 Cr. | 82.5 | 141/76.3 | 18.4 | 48.6 | 1.45 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 332 Cr. | 151 | 179/67.8 | 32.9 | 35.8 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 24,619 Cr. | 9,828 | 10,691/6,220 | 116 | 308 | 0.33 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 2,072 Cr. | 717 | 843/544 | 38.0 | 113 | 0.64 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 190 Cr. | 90.3 | 137/85.0 | 7.23 | 86.4 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 67,291 Cr. | 5,628 | 5,961/4,492 | 29.6 | 1,002 | 0.80 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 18,182 Cr. | 924 | 1,153/725 | 30.7 | 264 | 1.19 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 504 Cr. | 883 | 1,540/763 | 80.1 | 688 | 0.57 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 31,741 Cr. | 2,539 | 3,148/2,022 | 32.6 | 345 | 1.10 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,572 Cr. | 319 | 509/258 | 26.1 | 127 | 1.63 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 4,633 Cr. | 503 | 575/312 | 25.9 | 136 | 0.20 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 19,966.35 Cr | 1,197.73 | | 54.46 | 195.30 | 0.33% | 16.24% | 14.95% | 6.10 |